1. Home
  2. TAOP vs OSRH Comparison

TAOP vs OSRH Comparison

Compare TAOP & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TAOP

Taoping Inc.

HOLD

Current Price

$1.30

Market Cap

13.2M

Sector

Technology

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.59

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAOP
OSRH
Founded
1993
N/A
Country
China
United States
Employees
N/A
21
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
11.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
TAOP
OSRH
Price
$1.30
$0.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.0K
680.1K
Earning Date
04-28-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.38
52 Week High
$8.78
$3.30

Technical Indicators

Market Signals
Indicator
TAOP
OSRH
Relative Strength Index (RSI) 44.61 61.05
Support Level $1.23 $0.51
Resistance Level $1.59 $0.59
Average True Range (ATR) 0.22 0.06
MACD -0.01 0.02
Stochastic Oscillator 17.35 74.48

Price Performance

Historical Comparison
TAOP
OSRH

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: